# First-line Therapy of Stage IV Colorectal Cancer

> **NCT00784446** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Cologne** · enrollment: 51 (actual)

## Conditions studied

- Stage IV Colorectal Cancer

## Interventions

- **DRUG:** Oxaliplatin, Capecitabine, Bevacizumab, Imatinib

## Key facts

- **NCT ID:** NCT00784446
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-08
- **Final completion:** 2012-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784446, "First-line Therapy of Stage IV Colorectal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00784446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*